Cover: Existing indicators to measure the biomedical innovation ecosystem
Read Online

Existing indicators to measure the biomedical innovation ecosystem

A targeted landscape review for FasterCures

by Advait Deshpande, Courtney Hood, Brandi Leach, Susan Guthrie

Download eBook for Free

FormatFile SizeNotes
PDF file 5.6 MB

Use Adobe Acrobat Reader version 10 or higher for the best experience.

This working paper describes a targeted landscape review conducted in order to assess evidence in the existing literature regarding the characterisation and measurement of the biomedical innovation ecosystem. For the purposes of this paper, we use the term biomedical innovation ecosystem to encompass a dynamic network of activity which connects and combines different aspects of the therapeutic supply chain, including R&D, the pharmaceutical industry supply chain, medical professionals, regulatory and legislative elements of the drug testing and approval process, and deployment and adoption of the innovation and research outcomes.

The aim of the work is to identify existing indicators for the biomedical innovation ecosystem, as well as exploring wider considerations necessary in the conceptualisation and evaluation of the ecosystem. The work was conducted to support FasterCures as part of their wider project to develop a scorecard to measure the performance of the biomedical innovation ecosystem. The work is likely to be of interest to research funders and evaluators, particular those looking to develop indicators, or those interested in evaluation at a system level.

Table of Contents

  • Chapter One

    Introduction and context

  • Chapter Two

    Measuring the performance of the biomedical innovation ecosystem

  • Chapter Three

    Indicators

  • Chapter Four

    Discussion

  • Annex A

    Methods

  • Annex B

    Overview of a range of indicators used in the evaluation and assessment of academic biomedical and health research

  • Annex C

    TRIS indicators

Research conducted by

The research described in this report was prepared for FasterCures, a Center of the Milken Institute, and conducted by RAND Europe.

This report is part of the RAND Corporation Working paper series. RAND working papers are intended to share researchers' latest findings and to solicit informal peer review. They have been approved for circulation by RAND but may not have been formally edited or peer reviewed.

This document and trademark(s) contained herein are protected by law. This representation of RAND intellectual property is provided for noncommercial use only. Unauthorized posting of this publication online is prohibited; linking directly to this product page is encouraged. Permission is required from RAND to reproduce, or reuse in another form, any of its research documents for commercial purposes. For information on reprint and reuse permissions, please visit www.rand.org/pubs/permissions.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.